In the second study, although patients on acebutolol had a numerically lower incidence of new-onset AF than those on diltiazem and placebo, the difference did not reach statistical significance ( p = 0.067) [ 61 ].
← all excerpts
Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review.
1
0.0670
0.0670